(Q37135687)

18 August 2017

Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug (English)

1 reference

head and neck squamous cell carcinoma

18 August 2017

1 reference

1 reference

6

Shuming Nie

1 reference

18 August 2017

Nabil F Saba

1

1 reference

18 August 2017

Xu Wang

2

1 reference

18 August 2017

Susan Müller

3

1 reference

18 August 2017

Mourad Tighiouart

4

1 reference

18 August 2017

Kwangjae Cho

5

1 reference

18 August 2017

Zhuo Chen

7

1 reference

18 August 2017

Dong M Shin

8

1 reference

18 August 2017

language of work or name

1 reference

1 April 2009

1 reference

18 August 2017

1 reference

18 August 2017

31

1 reference

18 August 2017

4

1 reference

18 August 2017

475-481

1 reference

18 August 2017

Cancer statistics, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Folate-linked lipid-based nanoparticle for targeted gene delivery.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

UMSCC38 cells amplified at 11q13 for the folate receptor synthesize a mutant nonfunctional folate receptor

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Folate-maytansinoids: target-selective drugs of low molecular weight

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Immunohistochemical expression of folate receptor alpha in colorectal carcinoma: patterns and biological significance.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Folate receptor-targeted drugs for cancer and inflammatory diseases

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Synthesis and evaluation of taxol-folic acid conjugates as targeted antineoplastics

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2658731

3 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/19072997

12 December 2020

inferred from PubMed ID database lookup

Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19072997

12 December 2020

inferred from PubMed ID database lookup

Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19072997

12 December 2020

inferred from PubMed ID database lookup

Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FHED.21003

7 January 2021

inferred from DOI database lookup

On the Interpretation of χ 2 from Contingency Tables, and the Calculation of P

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FHED.21003

7 January 2021

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FHED.21003

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/HED.21003

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19072997

1 reference